Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis

Challenging the paradigm of progesterone-only therapy for early endometrial cancer: Results of a prospective trial of the levonorgestrel intrauterine system

(2016) S.N. Westin et al.   GYNECOLOGIC ONCOLOGY

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study

(2016) Jin-Sung Yuk   PeerJ

Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials

(2015) Hatem Abu Hashim et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential

(2015) Stanislav Mikhailovich Pronin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

(2015) Lesley A. Stewart et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial

(2013) A Ørbo et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Diagnosis and Management of Endometrial Hyperplasia

(2012) Amy J. Armstrong et al.   Journal of Minimally Invasive Gynecology

Use of Levonorgestrel-Releasing Intrauterine System in the Prevention and Treatment of Endometrial Hyperplasia

(2012) Ayman A.A. Ewies et al.   OBSTETRICAL & GYNECOLOGICAL SURVEY

Efficacy of Levonorgestrel-Releasing Intrauterine System Versus Oral Progestins in Treatment of Simple Endometrial Hyperplasia Without Atypia

(2012) Mohamed Taha Ismail et al.   Reproductive Sciences